Compare Macerich Company (The) Common Stock (MAC) vs Vaxcyte Inc. Common Stock (PCVX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Macerich Company (The) Common Stock vs Vaxcyte Inc. Common Stock — how do they compare? Macerich Company (The) Common Stock trades at $22.18 (market cap $6.39B), while Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B). The key difference: Vaxcyte Inc. Common Stock is the larger of the two by market cap, and Macerich Company (The) Common Stock pays a 3.02% dividend while Vaxcyte Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Macerich Company (The) Common Stock for 0 Days and Vaxcyte Inc. Common Stock for 0 Days on average.
| MAC | PCVX | |
|---|---|---|
Market Cap | $6.39B | $10.51B |
Volume | 2,684,151 | 2,644,694 |
Sector | Real Estate | Health |
52-Week High | $26.51 | $73.82 |
52-Week Low | $16.20 | $40.32 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $11.07B | $9.14B |
Dividend Yield | 3.02% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Macerich Company (The) Common Stock
The Macerich Company is a real estate investment trust that owns, operates, and redevelops shopping centers concentrated in California, the Pacific Northwest, and other major US markets.
Read more on MAC →About Vaxcyte Inc. Common Stock
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →
